Prelude Capital Management’s CareTrust REIT CTRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,037
Closed -$588K 1290
2026
Q1
$588K Buy
+16,037
New +$616K 0.04% 448
2019
Q2
Sell
-13,831
Closed -$324K 1752
2019
Q1
$324K Sell
13,831
-7,144
-34% -$156K 0.02% 586
2018
Q4
$387K Buy
20,975
+9,342
+80% +$174K 0.03% 536
2018
Q3
$206K Buy
+11,633
New +$205K 0.01% 753
2017
Q4
Sell
-1,200
Closed -$23K 1416
2017
Q3
$23K Buy
+1,200
New +$22.5K ﹤0.01% 1285
2016
Q3
Sell
-300
Closed -$4K 1624
2016
Q2
$4K Buy
+300
New +$3.96K ﹤0.01% 1474

Other funds holding CTRE

Prelude Capital Management's CTRE Position: Q2 2026 in Review

Prelude Capital Management sold out of CareTrust REIT (CTRE) in Q2 2026, closing a stake of 16,037 shares — an estimated $588K sold.

Prelude Capital Management first reported a position in CTRE in Q2 2016 and held it in 6 quarters. The position peaked at $588K in Q1 2026. 512 funds tracked by Wall St. Rank hold CTRE as of Q2 2026.

  • Prelude Capital Management reported no remaining CareTrust REIT position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 16,037 CareTrust REIT shares in Q2 2026, an estimated $588K.
  • Prelude Capital Management first reported a position in CareTrust REIT in Q2 2016 and held it in 6 quarters.
  • Prelude Capital Management's CareTrust REIT position peaked at $588K in Q1 2026.
  • 512 funds tracked by Wall St. Rank held CareTrust REIT as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.